FDA Approved: SPINRAZA — Supplemental Application (Biogen Inc.)

View source ↗

Summary

FDA approved a supplemental application for Spinraza (nusinersen) filed by Biogen, updating the drug's regulatory status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Muscular Atrophy

Drugs mentioned

• Spinraza (nusinersen)

Snippet

SUPPL AP for SPINRAZA (NUSINERSEN)